{'fraction_non_alphanumeric': 0.027633851468048358, 'fraction_numerical': 0.018998272884283247, 'mean_word_length': 4.858585858585859, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The IUD revisited.


 Clinical experience with the Dalkon Shield IUD, especially among nulliparous adolescents, is briefly reported. Expulsion rates with other IUDs had been unacceptably high among nulliparas. However, there were only 6 expulsions and 1 pregnancy among 31 parous and 45 nulliparous women (age range 12-22) who received the Shield. Pain, bleeding, and/or pelvic inflammatory disease accounted for 6 removals. It is pointed out that the removal of the Dalkon Shield from the market leaves high-risk adolescent females with a very limited choice of contraceptives.
